| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.098 | 0.5 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.097 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.096 | 0.7 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.093 | 0.6 |